Cas:70375-23-4 Z-Pro-Arg-AMC · HCl manufacturer & supplier

Chemical Name:Z-Pro-Arg-AMC · HCl

CAS.NO:70375-23-4

Synonyms:Z-Pro-Arg 7-amido-4-methylcoumarin hydrochloride;Z-Pro-Arg-AMC;Z-Pro-Arg-AMC · HCl

Molecular Formula:C₂₉H₃₅ClN₆O₆

Molecular Weight:599.07800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:179.85000

Exact Mass:598.23100

LogP:4.98390

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Z-Pro-Arg 7-amido-4-methylcoumarin hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Z-Pro-Arg-AMC · HCl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Z-Pro-Arg 7-amido-4-methylcoumarin hydrochloride Use and application,Z-Pro-Arg-AMC · HCl technical grade,usp/ep/jp grade.

Related News: Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available. (Z)-2-(6-chloro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)-1-(adamantan-1-yl)ethan-1-one, hydrochloride manufacturers But one clear concern among the CDC’s expert group this time around was the rapidly spreading Delta variant, first found in India. That mutated strain now accounts for over 80% of new U.S. infections that are sequenced, CDC data shows. 1-chloro-1-(3,4-dichloro-phenyl)-3-phenyl-propane suppliers Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available. [RuCl(CO)(NCCH3)2(P(i)Pr3)2]BF4 vendor & factory As we expand our offering into the US and beyond, NOVA aims to become the go-to partner for pharma and biotech companies for in silico clinical trial support. I am delighted to welcome Grégoire to the Novadiscovery team and look forward to working closely with him.”,Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available.